How useful is chemotherapy for atypical and anaplastic meningiomas?-Reference-Cited by-同舟云学术

How useful is chemotherapy for atypical and anaplastic meningiomas?

Published:2022-09-22 Issue:14 Volume:23 Page:1559-1561
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Drappatz Jan¹

Affiliation:

1. Departments of Neurology and Medicine, Division of Hematology and Oncology, Center for Neuro-Oncology, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2022.2131394

Reference17 articles.

1. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

2. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic

3. Pathological classification and molecular genetics of meningiomas

4. Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting response to chemotherapy in brain tumor patients based on MRI features;Clinical Neurology and Neurosurgery;2024-09

2. Examining the Causal Connection between Lipid-lowering Medications and Malignant Meningiomas through Drug-target Mendelian Randomization Analysis;IgMin Research;2024-05-15

3. Clinicopathological characteristics and prognostic factors of atypical meningiomas with bone invasion: a retrospective analysis of nine cases and literature review;Romanian Journal of Morphology and Embryology;2024-01-04

4. Domestic Animal Models of Central Nervous System Tumors: Focus on Meningiomas;Life;2023-11-30

5. Advances in the systemic therapy for recurrent meningiomas and the challenges ahead;Expert Review of Neurotherapeutics;2023-09-11